Filter Results :

Your search for returned 457322 reports

Sort by


20s Proteasome Inhibitors -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, 20s Proteasome Inhibitors-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the 20s Proteasome Inhibitors. The DelveInsights Report covers the product profiles in various stages of development including Disc...

$ 1,250.00

Read More

30S Ribosomal Subunit (30S RNA) Inhibitors -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, 30S Ribosomal Subunit (30S RNA) Inhibitors-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the 30S Ribosomal Subunit (30S RNA) Inhibitors. The DelveInsights Report covers the product profiles in various st...

$ 1,250.00

Read More

4-1BB (CD137) Agonist -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, 4-1BB (CD137) Agonist-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the 4-1BB (CD137) Agonist. The DelveInsights Report covers the product profiles in various stages of development including Discovery, P...

$ 1,250.00

Read More

50S Ribosomal Subunit (50S RNA) Inhibitors -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, 50S Ribosomal Subunit (50S RNA) Inhibitors-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the 50S Ribosomal Subunit (50S RNA) Inhibitors. The DelveInsights Report covers the product profiles in various st...

$ 1,250.00

Read More

5-Alpha Reductase Inhibitors -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, 5-Alpha Reductase Inhibitors-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the 5-Alpha Reductase Inhibitors. The DelveInsights Report covers the product profiles in various stages of development includin...

$ 1,250.00

Read More

5-HT1 Agonists -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, 5-HT1 Agonists-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the 5-HT1 Agonists. The DelveInsights Report covers the product profiles in various stages of development including Discovery, Pre-clinical, I...

$ 1,250.00

Read More

5-HT1 Antagonists -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, 5-HT1 Antagonists-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the 5-HT1 Antagonists. The DelveInsights Report covers the product profiles in various stages of development including Discovery, Pre-clini...

$ 1,250.00

Read More

5-HT1A Antagonists -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, 5-HT1A Antagonists-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the 5-HT1A Antagonists. The DelveInsights Report covers the product profiles in various stages of development including Discovery, Pre-cli...

$ 1,250.00

Read More

5-HT1B Agonists -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, 5-HT1B Agonists-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the 5-HT1B Agonists. The DelveInsights Report covers the product profiles in various stages of development including Discovery, Pre-clinical,...

$ 1,250.00

Read More

5-HT1B Antagonists -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, 5-HT1B Antagonists-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the 5-HT1B Antagonists. The DelveInsights Report covers the product profiles in various stages of development including Discovery, Pre-cli...

$ 1,250.00

Read More

5-HT1D Agonists -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, 5-HT1D Agonists-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the 5-HT1D Agonists. The DelveInsights Report covers the product profiles in various stages of development including Discovery, Pre-clinical,...

$ 1,250.00

Read More

5-HT1F Agonists -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, 5-HT1F Agonists-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the 5-HT1F Agonists. The DelveInsights Report covers the product profiles in various stages of development including Discovery, Pre-clinical,...

$ 1,250.00

Read More

5-HT2 Antagonists -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, 5-HT2 Antagonists-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the 5-HT2 Antagonists. The DelveInsights Report covers the product profiles in various stages of development including Discovery, Pre-clini...

$ 1,250.00

Read More

5-HT2A Agonists -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, 5-HT2A Agonists-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the 5-HT2A Agonists. The DelveInsights Report covers the product profiles in various stages of development including Discovery, Pre-clinical,...

$ 1,250.00

Read More

5-HT2B Antagonists -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, 5-HT2B Antagonists-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the 5-HT2B Antagonists. The DelveInsights Report covers the product profiles in various stages of development including Discovery, Pre-cli...

$ 1,250.00

Read More
Total 457322 records.